Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	FexaLieve (General sale)
Active Ingredient:	Fexofenadine hydrochloride 120mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Dr Reddy’s New Zealand Limited
Manufacturers:	Dr Reddy’s Laboratories Limited, Bachupally, India Dr Reddy’s Laboratories Limited, Qutubullapur Mandal, India

*Product:*	FexaLieve (Pharmacy only)
Active Ingredient:	Fexofenadine hydrochloride 120mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Dr Reddy’s New Zealand Limited
Manufacturers:	Dr Reddy’s Laboratories Limited, Bachupally, India Dr Reddy’s Laboratories Limited, Qutubullapur Mandal, India

*Product:*	FexaLieve
Active Ingredient:	Fexofenadine hydrochloride 180mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Dr Reddy’s New Zealand Limited
Manufacturers:	Dr Reddy’s Laboratories Limited, Bachupally, India Dr Reddy’s Laboratories Limited, Qutubullapur Mandal, India

*Product:*	Hayfexo
Active Ingredient:	Fexofenadine hydrochloride 120mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Dr Reddy’s New Zealand Limited
Manufacturers:	Dr Reddy’s Laboratories Limited, Bachupally, India Dr Reddy’s Laboratories Limited, Qutubullapur Mandal, India

*Product:*	Hayfexo
Active Ingredient:	Fexofenadine hydrochloride 180mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Dr Reddy’s New Zealand Limited
Manufacturers:	Dr Reddy’s Laboratories Limited, Bachupally, India Dr Reddy’s Laboratories Limited, Qutubullapur Mandal, India

Dated this 11th day of March 2024.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule